Digital Therapeutics

Cognitive behavioral therapy (CBT) delivered through interactive software modules. Biofeedback using smartphone sensors and wearables. Gamification to improve adherence and engagement. AI personalization adapting therapeutic content to individual patient needs and progress. Digital biomarkers measuring treatment response through device interactions.

FDA-authorized apps deliver CBT for insomnia without medication. DTx programs treat substance use disorder through structured behavioral interventions. Biofeedback-based DTx treats PTSD and panic disorder. Digital programs manage chronic conditions (diabetes, cardiovascular) through behavior change. ADHD treatment through attention-training games.

The global digital therapeutics market was valued at approximately $5 billion in 2025, though the category has underperformed initial projections due to reimbursement challenges. The addressable market for software-based treatment of chronic conditions is enormous if payer coverage expands.